The main cost drivers in dementia: A systematic review

International Journal of Geriatric Psychiatry

Volumn 30, Issue 2, 2015, Pages 111-129

  Schaller, Sandra ^a   Mauskopf, Josephine ^b   Kriza, Christine ^a   Wahlster, Philip ^a   Kolominsky Rabas, Peter L ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b RTI HEALTH SOLUTIONS   (United States)

Author keywords

Alzheimer's disease; Care setting; Cost of illness; Dementia; Economics; Health policy

Indexed keywords

COST OF ILLNESS; DEMENTIA; DISEASE SEVERITY; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; NURSING HOME; OUTPATIENT CARE; PREVALENCE; REVIEW; SYSTEMATIC REVIEW; ECONOMICS; HEALTH CARE DELIVERY; MENTAL HEALTH SERVICE;

COST OF ILLNESS; DELIVERY OF HEALTH CARE; DEMENTIA; HEALTH CARE COSTS; HUMANS; MENTAL HEALTH SERVICES;

EID: 84921018793     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4198     Document Type: Review

References (65)

1. Allegri RF, Butman J, Arizaga RL, et al. 2007. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina. Int Psychogeriatr 19: 705-718.
2. Alzheimer's Disease International (ADI). 2008. The prevalence of dementia worldwide. Alzheimer's Disease International, London.
3. Alzheimer's Disease International (ADI). 2009. World Alzheimer's report 2009. Alzheimer's Disease International, London, p. 18. http://www.alz.co.uk/research/files/WorldAlzheimerReport.pdf
4. Alzheimer's Disease International (ADI). 2010. World Alzheimer Report 2010: The Global Economic Impact of Dementia. Alzheimer's Disease International, London.
5. American Psychiatric Association. 1994 Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
6. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders.
7. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. 2005. Cost of disorders of the brain in Europe. Eur J Neurol 12(Suppl 1): 1-27.
8. Beeri MS, Werner P, Adar Z, Davidson M, Noy S. 2002. Economic cost of Alzheimer disease in Israel. Alzheimer Dis Assoc Disord 16: 73-80.
9. Bloom BS, Bruno DJ, Maman DY, Jayadevappa R. 2001. Usefulness of US cost-of-illness studies in healthcare decision making. Pharmacoeconomics 19: 207-213.
10. Bloom BS, de Pouvourville N, Straus WL. 2003. Cost of illness of Alzheimer's disease: how useful are current estimates? Gerontologist 43: 158-164.
11. Brodaty H, Donkin M. 2009. Family caregivers of people with dementia. Dialogues Clin Neurosci 11(2): 217-228.
12. Chan ALF, Cham T-M, Lin S-J. 2009. Direct medical costs in patients with Alzheimer's disease in Taiwan: a population-based study. Curr Ther Res 70: 10-18.
13. Coduras A, Rabasa I, Frank A, et al. 2010 Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study. J Alzheimers Dis 19: 601-615.
14. Costa N, Derumeaux H, Rapp T, et al. 2012 Methodological considerations in cost of illness studies on Alzheimer disease. Health Econ Rev 2: 18.
15. Costa N, Ferlicoq L, Derumeaux-Burel H, et al. 2013 Comparison of informal care time and costs in different age-related dementias: a review. BioMed Res Int 2013: 852368.
16. Drummond MF, Jefferson TO. 1996. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 313: 275-283.
17. Ernst RL, Hay JW. 1997 Economic research on Alzheimer disease: a review of the literature. Alzheimer Dis Assoc Disord 11(Suppl 6): 135-145.
18. Eska K, Graessel E, Donath C, et al. 2013 Predictors of institutionalization of dementia patients in mild and moderate stages: a 4-year prospective analysis. Dement Geriatr Cogn Dis Extra 3: 426-445.
19. Evers S, Goossens M, de Vet H, van Tulder M, Ament A. 2005. Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria. Int J Technol Assess Health Care 21: 240-245.
20. Fillit H, Hill J. 2005. Economics of dementia and pharmacoeconomics of dementia therapy. Am J Geriatr Pharmacother 3: 39-49.
21. Gustavsson A, Jonsson L, Rapp T, et al. 2010. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study. J Nutr Health Aging 14(8): 648-654.
22. Gustavsson A, Brinck P, Bergvall N, et al. 2011a. Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients. Alzheimers Dement 7: 318-327.
23. Gustavsson A, Cattelin F, Jonsson L. 2011b. Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants. Alzheimers Dement 7: 466-473.
24. Gustavsson A, Svensson M, Jacobi F, et al. 2011c. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21 (10): 718-779. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012; 22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].
25. Herrmann N, Lanctot KL, Sambrook R, et al. 2006. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry 21: 972-976.
26. Jakobsen M, Poulsen PB, Reiche T, Nissen NP, Gundgaard J. 2011. Costs of informal care for people suffering from dementia: evidence from a Danish survey. Dement Geriatr Cogn Dis Extra 1: 418-428.
27. Jonsson L, Wimo A. 2009. The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics 27: 391-403.
28. Jonsson L, Eriksdotter Jonhagen M, Kilander L, et al. 2006. Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry 21: 449-459.
29. Kang IO, Lee SY, Kim SY, Park CY. 2007. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea. Int J Geriatr Psychiatry 22: 675-681.
30. Kraft E, Marti M, Werner S, Sommer H. 2010. Cost of dementia in Switzerland. Swiss Med Wkly 140: w13093.
31. Larg A, Moss JR. 2011. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics 29: 653-671.
32. Leicht H, Heinrich S, Heider D, et al. 2011. Net costs of dementia by disease stage. Acta Psychiatr Scand 124: 384-395.
33. Leung GM, Yeung RY, Chi I, Chu LW. 2003. The economics of Alzheimer disease. Dement Geriatr Cogn Disord 15: 34-43.
34. Livingston G, Katona C, Roch B, Guilhaume C, Rive B. 2004. A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care - the LASER-AD Study. Curr Med Res Opin 20: 1007-1016.
35. Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J. 2006. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology 67: 2186-2191.
36. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. 2010. Alzheimer's disease: clinical trials and drug development. Lancet Neurol 9: 702-716.
37. Mauskopf J, Mucha L. 2011. A review of the methods used to estimate the cost of Alzheimer's disease in the United States. Am J Alzheimers Dis Other Demen 26: 298-309.
38. Mauskopf J, Racketa J, Sherrill E. 2010. Alzheimer's disease: the strength of association of costs with different measures of disease severity. J Nutr Health Aging 14: 655-663.
39. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
40. Mesterton J, Wimo A, By A, et al. 2010. Cross sectional observational study on the societal costs of Alzheimer's disease. Curr Alzheimer Res 7: 358-367.
41. Moher D, Liberati A, Tetzlaff J, Altman DG. 2011. PRISMA statement. Epidemiology 22(1): 128.
42. Murman DL, Von Eye A, Sherwood PR, Liang J, Colenda CC. 2007. Evaluated need, costs of care, and payer perspective in degenerative dementia patients cared for in the United States. Alzheimer Dis Assoc Disord 21: 39-48.
43. Newcomer RJ, Clay TH, Yaffe K, Covinsky KE. 2005. Mortality risk and prospective medicare expenditures for persons with dementia. J Am Geriatr Soc 53: 2001-2006.
44. OECD. 2014. PPPs and exchange rates. Available at http://stats.oecd.org/Index.aspx?DataSetCode=PPPGDP (data extracted on 07 Jul 2014 11:46 UTC (GMT) from OECD.Stat).
45. Prince M, Bryce R, Albanese E, et al. 2013. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9(1): 63-75.e2.
46. Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, Konig HH. 2010. Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand 121: 243-259.
47. Rapp T, Andrieu S, Molinier L, et al. 2012. Exploring the relationship between Alzheimer's disease severity and longitudinal costs. Value Health 15: 412-419.
48. Reisberg B, Doody R, Stoffler A, et al. 2003. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348: 1333-1341.
49. Rigaud AS, Fagnani F, Bayle C, et al. 2003. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease. J Geriatr Psychiatry Neurol 16: 140-145.
50. Schwarzkopf L, Menn P, Kunz S, et al. 2011. Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health 14: 827-835.
51. Schwarzkopf L, Menn P, Leidl R, et al. 2012. Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data. BMC Health Serv Res 12: 165.
52. Skoldunger A, Wimo A, Johnell K. 2012. Net costs of dementia in Sweden - an incidence based 10 year simulation study. Int J Geriatr Psychiatry 27: 1112-1117.
53. Suh GH, Knapp M, Kang CJ. 2006. The economic costs of dementia in Korea, 2002. Int J Geriatr Psychiatry 21: 722-728.
54. Wang G, Cheng Q, Zhang S, et al. 2008. Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai, China. J Alzheimers Dis 15: 109-115.
55. Wilcock GK. 2003. Memantine for the treatment of dementia. Lancet Neurol 2: 503-505.
56. Wimo A. 2010. The art of cost of illness. J Alzheimers Dis 19: 617-619.
57. Wimo A, Winblad B. 2003. Societal burden and economics of vascular dementia: preliminary results from a Swedish-population-based study. Int Psychogeriatr 15 (Suppl 1): 251-256.
58. Wimo A, Ljunggren G, Winblad B. 1997. Costs of dementia and dementia care: a review. Int J Geriatr Psychiatry 12: 841-856.
59. Wimo A, Jonsson L, Gustavsson A, et al. 2011. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Int J Geriatr Psychiatry 26: 825-832.
60. Wimo A, Jonsson L, Bond J, Prince M, Winblad B. 2013. The worldwide economic impact of dementia 2010. Alzheimers Dement 9: 1-11.e3.
61. Yang Z, Zhang K, Lin PJ, Clevenger C, Atherly A. 2012. A longitudinal analysis of the lifetime cost of dementia. Health Serv Res 47: 1660-1678.
62. Zencir M, Kuzu N, Beser NG, et al. 2005. Cost of Alzheimer's disease in a developing country setting. Int J Geriatr Psychiatry 20: 616-622.
63. Zhu CW, Scarmeas N, Torgan R, et al. 2006a. Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community. J Am Geriatr Soc 54: 1596-1602.
64. Zhu CW, Scarmeas N, Torgan R, et al. 2006b. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology 67: 998-1005.
65. Zhu CW, Scarmeas N, Stavitsky K, et al. 2008. Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies. Alzheimers Dement 4: 280-284.